Day: August 3, 2020

Business Services
Cloud-based
TradersPro Alerts

Cloudera, Inc. (CLDR) Buy Target $11.67 Sell Target $12.80

Trade Setup Buy Target: $11.67 Sell Target: 12.80 Cloudera, Inc. provides a suite of data analytics and management products in the United States, Europe, and Asia. The company operates through two segments, Subscription and Services. It offers Cloudera Enterprise Data Hub that allows companies to execute various analytic functions against a shared set of governed […]

Read More
Biotech
Penny Stocks
TradersPro Penny Stocks

PURE Bioscience, Inc. (PURE)

Trade Setup Stocks found in this category are low priced stocks priced between .50 and $1, with at least 50k shares of average shares trading per day.   The stocks are pausing a trend either up or down, with a new bar over the prior day open or close.  These are high reward to risk stocks with the […]

Read More
Biomedical
Daily Rundown
Economy
Electric Vehicles
Google
Pharmaceuticals
Social Media
Stock Picks
Tech Stocks
US Economy

ADT Shares Skyrocket On New Deal With Google

Plus, stimulus stocks continue to sputter, Eli Lilly is beginning a late stage trial of its experimental coronavirus antibody treatment in nursing homes, Microsoft has 45 days to finalize a deal to buy TikTok, and another electric vehicle maker is going public via a merger with a blank-check SPAC.

Read More
One Hot Stock
Software

Magic Software Enterprises Ltd. (MGIC) – Buy Price: $13.00 or better

Buy Price: $13.00 or better Sell Price: TradersPro Sell Signal Magic Software Enterprises Ltd. provides proprietary application development, business process integration, vertical software solutions, and information technologies (IT) outsourcing software services in Israel and internationally. The company’s Software Services segment develops, markets, sells, and supports application platform, software applications, and business and process integration solutions […]

Read More
Fibonacci Retracement
Fundamental Analysis
Health
HeathCare
Pharmaceuticals
Technical Analysis
Value Investing
Value Stocks

Vaccine news puts GSK front and center of media attention – and it could be an interesting value buy, too

Most of us are certainly getting tired of continuing to hear and read about COVID-19. Daily statistics about infections, mortality rates, and rolling averages of both can really wear on even the most patient person. The truth, of course is that this isn’t something that is going to go away – not as long as […]

Read More